Fdc Sales Mis Online
Arjun had been a regional sales manager for eleven years. He had seen doctors change prescription habits, drug reps morph into digital avatars, and CRM tools evolve from paper diaries to AI-driven dashboards. But nothing—nothing—had prepared him for the silence that came after the launch of the new FDC.
He pulled up the prescription trend for Dr. Meera Iyengar, a pulmonologist in the city’s top lung hospital. Her prescription numbers for Nebuflam-D had gone from zero to forty in the first week—after his star rep had visited her thrice—and then dropped to two in the third week. But the MIS showed zero patient redemptions from her prescriptions. That meant either patients weren’t buying it, or the prescriptions were never written.
But who? A rep desperate to meet target? A stockist colluding with a retailer? Or the MIS itself—not the software, but the people who controlled what data entered it.
He walked out of the data entry room, past the janitor who had stopped humming, past the empty cubicles, past the motivational posters that said “Data is the new science.” Fdc Sales Mis
The drug was called Nebuflam-D . A fixed-dose combination of an expectorant, a low-dose steroid, and a novel mucolytic. It was supposed to be a blockbuster for chronic bronchitis. The clinical trials were solid. The pricing was aggressive. The sales force was incentivized to the teeth.
And yet, week four of the launch, the MIS dashboard showed a flat green line where a hockey stick should have been.
A pause. “Sir, she said the combination gave some patients palpitations. She switched to separate molecules.” Arjun had been a regional sales manager for eleven years
On days when the company ran high-intensity sales blitzes, primary sales spiked—but redemption data showed no corresponding increase . In fact, on those days, the system recorded a suspiciously high number of prescriptions written after 9 PM , which was impossible because most clinics closed by 7.
And in the MIS, that whisper would never appear.
“Yes sir, forty scripts. I saw them myself. She wrote them in front of me.” He pulled up the prescription trend for Dr
“Rajesh gave me these,” she whispered. “He said, ‘Just enter them. The system will never know. The expiry dates are old anyway.’”
Outside, the city was asleep. But somewhere, a patient with chronic bronchitis was breathing shallowly, having bought only half a course of the expectorant, leaving the steroid untouched—because a chemist had whispered, “Don’t take this combo, beta. Too risky.”
He understood then what FDC sales MIS really was. Not a tool. Not a system. A mirror. And what it reflected was not the market, but the fear inside the people who sold drugs: fear of failure, fear of being fired, fear of a flat green line.
Arjun closed the drawer. He looked at the MIS dashboard on her screen—the same one his boss saw every morning. It glowed with confidence: green arrows, rising trends, forecast accuracy of 94%. None of it was real.
